Skip to content

ADOlescent DysmenoRrhea Endometriosis Assessment Magnetic Resonance Imaging (Adodream)

ADOlescent DysmenoRrhea Endometriosis Assessment Magnetic Resonance Imaging

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05153512
Acronym
Adodream
Enrollment
350
Registered
2021-12-10
Start date
2019-09-26
Completion date
2021-12-26
Last updated
2021-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Brief summary

To date, no MRI study has been published describing the prevalence of endometriosis in adolescent girls, not even in those with significant dysmenorrhea and therefore more particularly at risk. Likewise, there are no precise data on the type of superficial or early-onset deep endometriosis that appears in adolescence. The collection of these data would allow an earlier diagnosis, because it is better documented, of endometriosis. The lesions would then be treated earlier, avoiding their development and the problems of infertility related to this pathology. The aim of this sudy is to assess the prevalence of endometriosis and its phenotypic representation in the study population consulting for dysmenorrhea with suspected endometriosis.

Interventions

PROCEDUREMRI

Pelvic MRI without injection of contrast product and WITHOUT rectal or vaginal opacification

Sponsors

European Clinical Trial Experts Network
CollaboratorOTHER
Ramsay Générale de Santé
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
12 Years to 20 Years

Inclusion criteria

* Patient aged between 12 and 20 years old. * After menarche. * Requiring pelvic MRI for exploration of dysmenorrhea (after or not ultrasound), in the case of patients with suspected endometriosis, or for any other reason (cyst, tumor, non-obstructive urogenital malformations), in the case of patients without symptoms clinic associated with endometriosis. * Patient affiliated or beneficiary of a social security scheme. * Patient and her legal representative, if applicable, having been informed and not opposing this research.

Exclusion criteria

* Patient whose pelvic MRI is performed as part of an exploration of obstructive uterine malformations. * Patient claustrophobic, making it impossible to perform an MRI. * Contraindication to MRI: pacemaker, ferromagnetic object incompatible with MRI. * Pregnant, breastfeeding or parturient woman. * Protected patient: Major under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision; Hospitalized without consent.

Design outcomes

Primary

MeasureTime frame
Number of patient with endometriosis detected on MRI1 day

Countries

France

Contacts

Primary ContactJean-François Oudet
jf.oudet@ecten.eu0683346567
Backup ContactMarie-Hélène Barba
mh.barba@ecten.eu

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026